Regeneron Pharmaceuticals (REGN) traded to the upside throughout the first half of Wednesday's session and took out the highs of the day going into the close. The stock finished with a gain of 10.05 at $201.13.
Regeneron Pharmaceuticals has been gaining ground for nearly 2 weeks and set a new high for the year.
by RTT Staff Writer
For comments and feedback: firstname.lastname@example.org